{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:44Z","timestamp":1786120364045,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1524-4725.2012.02340.x","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T10:14:32Z","timestamp":1329387272000},"page":"722-727","source":"Crossref","is-referenced-by-count":26,"title":["Results of an Investigator-Initiated Single-Blind Split-Face Comparison of Photodynamic Therapy and 5% Imiquimod Cream for the Treatment of Actinic Keratoses"],"prefix":"10.1097","volume":"38","author":[{"given":"Jason","family":"Hadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Tristani-Firouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Florell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210206","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1067\/mjd.2000.108373","article-title":"Actinic keratosis is squamous cell carcinoma.","volume":"43","author":"Lober","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R2-2-20210206","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"R4-2-20210206","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00063030-199911050-00004","article-title":"A guide to immunotherapy of genital warts: focus on interferon and imiquimod.","volume":"11","author":"Czelusta","year":"1999","journal-title":"BioDrugs"},{"key":"R7-2-20210206","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.TP.0000107284.04969.5C","article-title":"Topical photodynamic therapy in the treatment of actinic keratoses and Bowens disease in transplant recipients.","volume":"77","author":"Dragieva","year":"2004","journal-title":"Transplantation"},{"key":"R8-2-20210206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1997.tb14934.x","article-title":"Quality of life measurement in dermatology: a practical guide.","volume":"136","author":"Finlay","year":"1997","journal-title":"Br J Dermatol"},{"key":"R9-2-20210206","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: what do dermatology life quality index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J Invest Dermatol"},{"key":"R10-2-20210206","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2133.2009.09260.x","article-title":"Effect of dosing frequency on the safety and efficacy of imiquimod 5 cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebocontrolled trial.","volume":"161","author":"Gebauer","year":"2009","journal-title":"Br J Dermatol"},{"key":"R11-2-20210206","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1997.03890420065007","article-title":"Photodynamic therapy of actinic keratosis with topical 5aminolevulinic acid. A pilot doseranging study.","volume":"133","author":"Jeffes","year":"1997","journal-title":"Arch Dermatol"},{"key":"R12-2-20210206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaad.2007.01.047","article-title":"Vehiclecontrolled, doubleblind, randomized study of imiquimod 5 cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.","volume":"57","author":"Jorizzo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R13-2-20210206","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaad.2005.06.010","article-title":"Efficacy of 3 different light doses in the treatment of actinic keratosis with 5aminolevulinic acid photodynamic therapy: a randomized, observerblinded, intrapatient, comparison study.","volume":"53","author":"RadakovicFijan","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R14-2-20210206","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1468-3083.2009.03259.x","article-title":"Intraindividual, rightleft comparison of topical 5aminolevulinic acid photodynamic therapy versus 5 imiquimod cream for actinic keratoses on the upper extremities.","volume":"23","author":"Sotiriou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-2-20210206","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3923\/pjbs.2009.929.933","article-title":"Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.","volume":"12","author":"Talghini","year":"2009","journal-title":"Pak J Biol Sci"},{"key":"R16-2-20210206","first-page":"246","article-title":"Elevated p53 protein expression in normal and neoplastic lightexposed epidermis.","volume":"78","author":"Sutter","year":"1994","journal-title":"Verh Dtsch Ges Pathol"},{"issue":"Suppl 2","key":"R18-2-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","article-title":"Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebocontrolled safety and efficacy study of imiquimod 5 cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.","volume":"157","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"},{"key":"R19-2-20210206","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2009.06.020","article-title":"Imiquimod 2.5 and 3.75 for the treatment of actinic keratoses: results of two placebocontrolled studies of daily application to the face and balding scalp for two 3week cycles.","volume":"62","author":"Hanke","year":"2010","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042728-201205000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:36:57Z","timestamp":1786048617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-201205000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2012.02340.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.716298027.791652989","asserted-by":"object"}]},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}